Watch the webinar by Prof. Fred Witjes
On Thursday 21 January 2021, MML-Medical, partner of Nucleix in the Netherlands, organised the webinar “Follow-up of NMIBC, including the place of urinary markers”. The webinar included 45 minutes lecture by Prof. Dr. Fred Witjes, Professor of oncological urology, and 15 minutes Q&A, chaired by Dr. Toine van der Heijden, oncological urologist, both from the Radboud UMC Nijmegen, the Netherlands.
Watch this webinar to learn more about:
- The current guidelines on treatment and follow-up of Non Muscle-Invasive Bladder Cancer (NMIBC)
- The pitfalls of the current follow-up procedures
- Urinary markers in follow-up of NMIBC and promising results from clinical studies
- Practical considerations about using biomarker tests in clinical practice